Correction: Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
- PMID: 39037481
- PMCID: PMC11263410
- DOI: 10.1007/s00345-024-05164-1
Correction: Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
Erratum for
-
Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.World J Urol. 2022 Aug;40(8):2063-2070. doi: 10.1007/s00345-022-04071-7. Epub 2022 Jun 30. World J Urol. 2022. PMID: 35773357 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
